<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65270">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01678638</url>
  </required_header>
  <id_info>
    <org_study_id>11-225-01</org_study_id>
    <nct_id>NCT01678638</nct_id>
  </id_info>
  <brief_title>Timing of Inguinal Hernia Repair in Premature Infants</brief_title>
  <official_title>Timing of Inguinal Hernia Repair in Premature Infants: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether early (before NICU discharge) or late
      (55-60 weeks post-menstrual age) inguinal hernia repair is safer for premature infants who
      have an inguinal hernia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized clinical trial comparing early versus late repair in premature infants
      with an inguinal hernia (IH) to determine which approach may be safer. Safety in this trial
      is defined as the freedom from significant adverse events, a reduction in hospital days
      during the study period, and normal neurodevelopmental testing at 2 years. Costs of each
      treatment strategy are also important and are being evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Significant adverse event (SAE) rate</measure>
    <time_frame>9 months beyond NICU discharge</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Specific significant adverse events that are either treatment related or hernia related have been defined a priori and will be assessed in both groups from randomization until 9 months after NICU discharge.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of hospital days</measure>
    <time_frame>From randomization until 9 months post NICU discharge</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Total number of hospital days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital costs</measure>
    <time_frame>Enrollment through 9 months after NICU discharge</time_frame>
    <safety_issue>No</safety_issue>
    <description>Departmental level costs at each participating institution will be determined for care that occurs from randomization until 9 months post NICU discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bayley Scales of Infant Development, 3rd Edition</measure>
    <time_frame>22-26 months corrected age</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Mean BSID scores; primarily cognitive domain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Prematurity</condition>
  <arm_group>
    <arm_group_label>Early inguinal hernia (IH) repair</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IH repair before NICU discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late inguinal hernia (IH) repair</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IH repair at 55-60 weeks post-menstrual age</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IH repair before NICU discharge</intervention_name>
    <description>The IH repair is performed prior to NICU discharge (within 1-2 weeks of enrollment and randomization)</description>
    <arm_group_label>Early inguinal hernia (IH) repair</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IH repair at 55-60 weeks post-menstrual age</intervention_name>
    <description>The IH repair will be performed between 55-60 weeks post-menstrual age.</description>
    <arm_group_label>Late inguinal hernia (IH) repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infant with estimated gestational age &lt; 37 weeks, 0 days

          -  In a NICU at participating site

          -  Diagnosed with an IH per the pediatric surgery team

          -  Parents and providers willing to randomize the infant

        Exclusion Criteria:

          -  Associated factor that impacts timing of IH repair  (e.g. clinical factors might
             preclude early IH repair)

          -  Infant is undergoing another operative procedure and IH repair is planned as a
             secondary procedure (e.g. fundoplication or G tube is planned, and IH repair is
             considered a secondary procedure)

          -  Known major congenital anomaly that impact neurodevelopmental outcome or chromosomal
             abnormality

          -  Family unable / unwilling to return for follow up and later IH repair; or likely
             unable to monitor IH as outpatient
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin L Blakely, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon E Tyson, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Health Science Center at Houston; Children's Memorial Hermann Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin L Blakely, MD, MS</last_name>
    <phone>6159361050</phone>
    <email>martin.blakely@vanderbilt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jamie Tice, BSN</last_name>
    <phone>6159361050</phone>
    <phone_ext>8749</phone_ext>
    <email>jamie.tice@vanderbilt.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham School of Medicine; Children's Hospital of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Russell, MD, MPH</last_name>
      <phone>205-638-9688</phone>
    </contact>
    <investigator>
      <last_name>Robert Russell, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences; Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sid Dassinger, MD</last_name>
      <phone>501-364-4000</phone>
    </contact>
    <investigator>
      <last_name>Sid Dassinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, Los Angeles David Geffen School of Medicine; Mattel Children's Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel DeUgarte, MD FACS FAAP</last_name>
      <phone>310-206-2429</phone>
    </contact>
    <investigator>
      <last_name>Daniel DeUgarte, MD FACS FAAP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California Keck School of Medicine; Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Akemi Kawaguchi, MD</last_name>
      <phone>323-361-5065</phone>
    </contact>
    <investigator>
      <last_name>Akemi Kawaguchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Medical Center; C.S. Mott Children's Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steven Bruch, MD, M.Sc</last_name>
      <phone>734-764-4151</phone>
    </contact>
    <investigator>
      <last_name>Steven Bruch, MD, M.Sc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical School; Amplatz Children's Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brad Segura, MD, PhD</last_name>
      <phone>612-365-6777</phone>
    </contact>
    <investigator>
      <last_name>Brad Segura, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Missouri- Kansas City Medical School; Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shawn St. Peter, MD</last_name>
      <phone>816-234-3199</phone>
    </contact>
    <investigator>
      <last_name>Shawn St. Peter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine in St. Louis; St. Louis Children's Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacqueline Saito, MD, MSCI</last_name>
      <phone>314-454-6022</phone>
    </contact>
    <investigator>
      <last_name>Jacqueline Saito, MD, MSCI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center; Duke Children's Hospital and Health Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Obinna Adibe, MD</last_name>
      <phone>919-681-5077</phone>
    </contact>
    <investigator>
      <last_name>Obinna Adibe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University College of Medicine; Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katherine Deans, MD, MHSc</last_name>
      <phone>614-722-3900</phone>
    </contact>
    <investigator>
      <last_name>Katherine Deans, MD, MHSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina; Medical University of South Carolina Children's Hospital</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Streck, MD FACS FAAP</last_name>
      <phone>843-792-3851</phone>
    </contact>
    <investigator>
      <last_name>Christian Streck, MD FACS FAAP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Health Science Center; Le Bonheur Children's Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eunice Huang, MD, MS</last_name>
      <phone>901-287-6031</phone>
    </contact>
    <investigator>
      <last_name>Eunice Huang, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Monroe Carell Jr. Children's Hospital at Vanderbilt</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin L Blakely, MD, MS</last_name>
      <phone>615-936-1050</phone>
      <email>martin.blakely@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jamie Tice, BSN</last_name>
      <phone>615-936-1050</phone>
      <phone_ext>8749</phone_ext>
      <email>jamie.tice@vanderbilt.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Blakely, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas, Southwestern Medical Center; Children's Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Li Ern Chen, MD</last_name>
      <phone>214-730-5437</phone>
    </contact>
    <investigator>
      <last_name>Li Ern Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine; Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monica Lopez, MD</last_name>
      <phone>832-822-3135</phone>
    </contact>
    <investigator>
      <last_name>Monica Lopez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston; Children's Memorial Hermann Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>KuoJen Tsao, MD</last_name>
      <phone>832-325-7234</phone>
    </contact>
    <investigator>
      <last_name>KuoJen Tsao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University Medical Center; Children's Hospital of Richmond</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jeffrey Haynes, MD FACS FAAP</last_name>
      <phone>804-828-3500</phone>
    </contact>
    <investigator>
      <last_name>Jeffrey Haynes, MD FACS FAAP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington School of Medicine; Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adam Goldin, MD, MPH</last_name>
      <phone>206-987-2794</phone>
    </contact>
    <investigator>
      <last_name>Adam Goldin, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin; Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Casey Calkins, MD</last_name>
      <phone>414-266-6550</phone>
    </contact>
    <investigator>
      <last_name>Casey Calkins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 5, 2013</lastchanged_date>
  <firstreceived_date>August 30, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Martin Blakely</investigator_full_name>
    <investigator_title>Associate Professor of Pediatric Surgery and Pediatrics</investigator_title>
  </responsible_party>
  <keyword>inguinal hernia</keyword>
  <keyword>prematurity</keyword>
  <keyword>anesthesia safety</keyword>
  <keyword>neurodevelopmental outcome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
